VisionPoint Advisory Group’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$277K Buy
443
+29
+7% +$17K 0.04% 368
2026
Q2
$219K Sell
414
-37
-8% -$17.1K 0.04% 446
2026
Q1
$217K Buy
451
+26
+6% +$13.3K 0.04% 414
2025
Q4
$239K Sell
425
-25
-6% -$14.2K 0.05% 348
2025
Q3
$231K Buy
+450
New +$196K 0.05% 356
2024
Q3
– Sell
-69
Closed -$28.4K – 560
2024
Q2
$28.4K Buy
69
+29
+73% +$11.5K 0.01% 348
2024
Q1
$16.2K Sell
40
-2
-5% -$703 0.01% 406
2023
Q4
$12.9K Sell
42
-19
-31% -$5.13K ﹤0.01% 395
2023
Q3
$14.8K Buy
+61
New +$15.6K 0.01% 412

Other funds holding MEDP

VisionPoint Advisory Group's MEDP Position: Q3 2026 in Review

VisionPoint Advisory Group increased its Medpace (MEDP) stake by 7% in Q3 2026, buying an estimated $17K and bringing the position to 443 shares worth $277K. The position accounts for 0.04% of the portfolio, ranked #368.

VisionPoint Advisory Group first reported a position in MEDP in Q3 2023 and has held it in 9 quarters since. 143 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • VisionPoint Advisory Group held 443 shares of Medpace worth $277K as of Q3 2026.
  • VisionPoint Advisory Group bought 29 Medpace shares in Q3 2026, an estimated $17K.
  • Medpace made up 0.04% of VisionPoint Advisory Group's portfolio in Q3 2026, its #368 holding.
  • VisionPoint Advisory Group first reported a position in Medpace in Q3 2023 and has held it in 9 quarters since.
  • 143 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on VisionPoint Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.